Equitable Holdings heads into its July 30 earnings release with the Street firmly in its corner — but the stock is trading well below where analysts think it should be.
The analyst consensus heading into the print is unusually one-directional. Every firm that updated its view in the past three weeks raised its price target. UBS lifted to $68, Jefferies to $66, Evercore ISI to $65, with Keefe Bruyette and Mizuho both moving to $62. The mean target of $60.82 implies roughly 27% upside from the current price of $48.00 — a gap wide enough to suggest either that the Street is getting ahead of itself or that the market has been slow to reprice EQH's improving earnings trajectory. Barclays cut its target modestly to $50 while maintaining Overweight, a lone dissent in an otherwise bullish sweep. The EPS surprise factor score ranks in the 83rd percentile, meaning the company has beaten estimates consistently — context that underpins the Street's confidence.
Short interest tells a low-conviction story on the bear side. Bears have been steadily covering: short interest has fallen more than 40% over the past month, dropping to just 1.8% of the free float. Borrow costs are near-zero at 0.33%, and availability is essentially uncapped — every share that could be borrowed is available, with no meaningful squeeze pressure anywhere in the lending market. That combination suggests short sellers are not making an aggressive case ahead of this print.
Options positioning has actually eased off its recent defensiveness. The put/call ratio of 1.64 sits more than a standard deviation below its 20-day average of 1.76 — meaning options traders have pulled back on downside hedges relative to recent habit. That's a shift worth noting: earlier in July the PCR was consistently running above 1.80, and it has drifted lower as the earnings date approached. The stock itself is up 6.8% over the past month but slipped 2% on the week, giving back some gains while peers CRBG and VOYA posted similar weekly declines, suggesting sector-level softness rather than any EQH-specific concern.
Insider selling adds a note of caution. CEO Mark Pearson sold nearly $1.93 million of stock on July 20, and COO Jeffrey Hurd sold a combined $701,000 across July 15. Both also sold in mid-June. The 90-day net selling figure comes to roughly $8.2 million — not alarming at a company of this size, but consistent enough across the executive suite to register. The July 30 print will test whether the gap between a $48 stock price and a $61 analyst consensus reflects a genuine valuation opportunity or whether the Street needs to recalibrate its targets to meet the market's more measured read on EQH's growth trajectory.
See the live data behind this article on ORTEX.
Open EQH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
